QXL138AM

· Nammi Therapeutics Inc

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QXL138AM, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma [Phase 1]